Desloratadine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063797
  • May 2021
  • Pharmaceuticals
  • 123 Pages
The Desloratadine Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Abbott Laboratory, Apollo Pharmaceuticals, GlaxoSmithKline Plc, Mayne Pharma Inc, Mylan N V, Pfizer Inc, Schering Plough Corporation, Takeda Pharmaceutical Company Ltd, Teva Pharmaceutical Industry Ltd
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Desloratadine market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Desloratadine market is expected to attain Pre COVID-19 levels by mid-2022.

Desloratadine Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Desloratadine market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Desloratadine Market Competitive and Premeditated Analysis
In the Desloratadine report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Desloratadine research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Desloratadine Market:
The Desloratadine market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abbott Laboratory, Apollo Pharmaceuticals, GlaxoSmithKline Plc, Mayne Pharma Inc, Mylan N V, Pfizer Inc, Schering Plough Corporation, Takeda Pharmaceutical Company Ltd, Teva Pharmaceutical Industry Ltd

The Desloratadine market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Desloratadine Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Desloratadine market:
By Product Type
Injection
Freeze-dried Powder
End User
Hospitals
Clinics
Others


Regional Analysis of the Desloratadine market:
The Desloratadine market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Desloratadine report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Desloratadine market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Desloratadine market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Desloratadine market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Desloratadine market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Desloratadine market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Desloratadine market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Desloratadine market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Desloratadine market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Abbott Laboratory
  • Apollo Pharmaceuticals
  • GlaxoSmithKline Plc
  • Mayne Pharma Inc
  • Mylan N V
  • Pfizer Inc
  • Schering Plough Corporation
  • Takeda Pharmaceutical Company Ltd
  • Teva Pharmaceutical Industry Ltd
  • Injection
  • Freeze-dried Powder
  • Hospitals
  • Clinics
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Desloratadine Market Snapshot
          2.1.1. Global Desloratadine Market By Product Type,2019
               2.1.1.1.Injection
               2.1.1.2.Freeze-dried Powder
          2.1.2. Global Desloratadine Market By End User,2019
               2.1.2.1.Hospitals
               2.1.2.2.Clinics
               2.1.2.3.Others
          2.1.3. Global Desloratadine Market By End-use,2019
          2.1.4. Global Desloratadine Market By Geography,2019

3. Global Desloratadine Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Desloratadine Market Size (US$), By Product Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product Type, 2020
     4.2. Global Desloratadine Market Size (US$), By Product Type, 2018 – 2028

5. Global Desloratadine Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Desloratadine Market Size (US$), By End User, 2018 – 2028

6. Global Desloratadine Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Desloratadine Market Size (US$), By End-use, 2018 – 2028

7. Global Desloratadine Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Desloratadine Market Analysis, 2018 – 2028 
          7.2.1. North America Desloratadine Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Desloratadine Market Size (US$), By Product Type, 2018 – 2028
          7.2.3. North America Desloratadine Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Desloratadine Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Desloratadine Market Analysis, 2018 – 2028 
          7.3.1.  Europe Desloratadine Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Desloratadine Market Size (US$), By Product Type, 2018 – 2028
          7.3.3. Europe Desloratadine Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Desloratadine Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Desloratadine Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Desloratadine Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Desloratadine Market Size (US$), By Product Type, 2018 – 2028
          7.4.3. Asia Pacific Desloratadine Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Desloratadine Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Desloratadine Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Desloratadine Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Desloratadine Market Size (US$), By Product Type, 2018 – 2028
          7.5.3. Latin America Desloratadine Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Desloratadine Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Desloratadine Market Analysis, 2018 – 2028 
          7.6.1.  MEA Desloratadine Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Desloratadine Market Size (US$), By Product Type, 2018 – 2028
          7.6.3. MEA Desloratadine Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Desloratadine Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Desloratadine Providers
        8.4.1 Abbott Laboratory
                8.4.1.1 Business Description
                8.4.1.2 Abbott Laboratory Geographic Operations
                8.4.1.3 Abbott Laboratory Financial Information
                8.4.1.4 Abbott Laboratory Product Positions/Portfolio
                8.4.1.5 Abbott Laboratory Key Developments
        8.4.2 Apollo Pharmaceuticals
                8.4.2.1 Business Description
                8.4.2.2 Apollo Pharmaceuticals Geographic Operations
                8.4.2.3 Apollo Pharmaceuticals Financial Information
                8.4.2.4 Apollo Pharmaceuticals Product Positions/Portfolio
                8.4.2.5 Apollo Pharmaceuticals Key Developments
        8.4.3 GlaxoSmithKline Plc
                8.4.3.1 Business Description
                8.4.3.2 GlaxoSmithKline Plc Geographic Operations
                8.4.3.3 GlaxoSmithKline Plc Financial Information
                8.4.3.4 GlaxoSmithKline Plc Product Positions/Portfolio
                8.4.3.5 GlaxoSmithKline Plc Key Developments
        8.4.4 Mayne Pharma Inc
                8.4.4.1 Business Description
                8.4.4.2 Mayne Pharma Inc Geographic Operations
                8.4.4.3 Mayne Pharma Inc Financial Information
                8.4.4.4 Mayne Pharma Inc Product Positions/Portfolio
                8.4.4.5 Mayne Pharma Inc Key Developments
        8.4.5 Mylan N V
                8.4.5.1 Business Description
                8.4.5.2 Mylan N V Geographic Operations
                8.4.5.3 Mylan N V Financial Information
                8.4.5.4 Mylan N V Product Positions/Portfolio
                8.4.5.5 Mylan N V Key Developments
        8.4.6 Pfizer Inc
                8.4.6.1 Business Description
                8.4.6.2 Pfizer Inc Geographic Operations
                8.4.6.3 Pfizer Inc Financial Information
                8.4.6.4 Pfizer Inc Product Positions/Portfolio
                8.4.6.5 Pfizer Inc Key Developments
        8.4.7 Schering Plough Corporation
                8.4.7.1 Business Description
                8.4.7.2 Schering Plough Corporation Geographic Operations
                8.4.7.3 Schering Plough Corporation Financial Information
                8.4.7.4 Schering Plough Corporation Product Positions/Portfolio
                8.4.7.5 Schering Plough Corporation Key Developments
        8.4.8 Takeda Pharmaceutical Company Ltd
                8.4.8.1 Business Description
                8.4.8.2 Takeda Pharmaceutical Company Ltd Geographic Operations
                8.4.8.3 Takeda Pharmaceutical Company Ltd Financial Information
                8.4.8.4 Takeda Pharmaceutical Company Ltd Product Positions/Portfolio
                8.4.8.5 Takeda Pharmaceutical Company Ltd Key Developments
        8.4.9 Teva Pharmaceutical Industry Ltd
                8.4.9.1 Business Description
                8.4.9.2 Teva Pharmaceutical Industry Ltd Geographic Operations
                8.4.9.3 Teva Pharmaceutical Industry Ltd Financial Information
                8.4.9.4 Teva Pharmaceutical Industry Ltd Product Positions/Portfolio
                8.4.9.5 Teva Pharmaceutical Industry Ltd Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Desloratadine Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Desloratadine Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Desloratadine Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Desloratadine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Desloratadine Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Desloratadine Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Desloratadine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Desloratadine Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Desloratadine Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Desloratadine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Desloratadine Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Desloratadine Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Desloratadine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Desloratadine Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Desloratadine Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Desloratadine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Desloratadine: Market Segmentation 
FIG. 2 Global Desloratadine Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Desloratadine Market, By Product Type, 2019 (US$ Mn) 
FIG. 5 Global Desloratadine Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Desloratadine Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Desloratadine Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Desloratadine Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Desloratadine Providers, 2019
FIG. 11 Global Desloratadine Market Revenue Contribution, By Product Type, 2019 & 2028 (Value %) 
FIG. 12 Global Desloratadine Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Desloratadine Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Desloratadine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Desloratadine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Desloratadine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Desloratadine Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Desloratadine Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Desloratadine market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Desloratadine Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Desloratadine Market Value, By Segment1, 2018 – 2028
TABLE  North America Desloratadine Market Value, By Segment2, 2018 – 2028
TABLE  North America Desloratadine Market Value, By Country, 2018 – 2028
TABLE  Europe Desloratadine Market Value, By Segment1, 2018 – 2028
TABLE  Europe Desloratadine Market Value, By Segment2, 2018 – 2028
TABLE  Europe Desloratadine Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Desloratadine Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Desloratadine Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Desloratadine Market Value, By Country, 2018 – 2028
TABLE  Latin America Desloratadine Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Desloratadine Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Desloratadine Market Value, By Country, 2018 – 2028
TABLE  MEA Desloratadine Market Value, By Segment1, 2018 – 2028
TABLE  MEA Desloratadine Market Value, By Segment2, 2018 – 2028
TABLE  MEA Desloratadine Market Value, By Country, 2018 – 2028
TABLE  Abbott Laboratory: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Apollo Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mayne Pharma Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mylan N V: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Schering Plough Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Takeda Pharmaceutical Company Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceutical Industry Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Desloratadine Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Desloratadine Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Desloratadine Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Desloratadine Market, By Geography, 2019 (US$ Mn)
FIG.  Global Desloratadine Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Desloratadine Providers, 2016
FIG.  Global Desloratadine Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Freeze-dried Powder Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Desloratadine Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Clinics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Desloratadine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Desloratadine Market Value, 2018 – 2028, (US$ Mn)